Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2020JAMA Network OpenOpen Access

Insurance Status as a Surrogate for Social Determinants of Health in Cancer Clinical Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRebecca A. SnyderThe University of Texas MD Anderson Cancer CenterGCGeorge J. ChangThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Snyder et al. (2020) studied this question.

synapsesocial.com/papers/6a8a6d060e1a8f7244fd77c7https://doi.org/10.1001/jamanetworkopen.2020.3890
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement2018 · 92 citations
  2. 2Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings2020 · 48 citations
  3. 3Is There Validity in Propensity Score–Matched Estimates of Adjuvant Chemotherapy Effects for Patients With Rectal Cancer?2018 · 12 citations
  4. 4Eliminating Racial Disparities in Colorectal Cancer in the Real World: It Took a Village2013 · 206 citations
  5. 5A system‐based intervention to reduce Black‐White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers2019 · 81 citations